The groundbreaking therapy of the medication represents a exciting advance in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide568331.shotblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56174729